FTC raises concern about Novo Nordisk attempt to acquire obesity startup

It's the latest complication in a dramatic bidding war between Novo and Pfizer for Metsera.

November 5, 2025 Check out STAT+

Sponsored By

Happening tomorrow: Join STAT's Jason Mast and Damian Garde for wide-ranging discussion about what's ahead for Moderna, which is now facing political, social, and scientific headwinds. Register now for the virtual event. And be sure to read Jason's recent deep dive into Moderna's unraveling.

Adobe STAT+ | FTC raises concern about Novo Nordisk attempt to acquire obesity startup Metsera An agency official says the structure of the Novo Nordisk offer for Metsera, an obesity startup, may violate U.S. law. By Elaine Chen and Ed Silverman Appeals court judges seem skeptical of Trump administration's defense of capping NIH overhead payments Cuts to NIH research grants challenged by 22 states as an 'arbitrary and capricious' violation of federal laws By Jonathan Wosen STAT+ | Arena BioWorks, an ambitious biomedical institute backed by billionaires, abruptly shuts down The research organization, launched two years ago, drew top talent. But its ability to churn out startups depended on more funding By Allison DeAngelis and Jason Mast What is 'fake' CPR, and why do doctors sometimes do it? When CPR is performed to ease family pain, not resuscitate the patient, it's called a 'slow code.' Alex Hogan, host of STATus Report, examines the ethics. By Alex Hogan STAT+ | Recursion CEO Chris Gibson out as company head after 12 years He will be replaced by current R&D head and Chief Commercial Officer Najat Khan as the techbio positions itself for next phase of AI drug discovery. By Brittany Trang STAT+ | Investors back new biotech with heart disease treatment from China  The new biotech raised $185 million to run a global late stage trial of a hypertrophic cardiomyopathy medicine. By Allison DeAngelis Andrew Harnik/AP STAT+ | FDA digital advisers confront risks of therapy chatbots, weigh possible regulation The FDA's Digital Health Advisory Committee is meeting to discuss regulation of therapy chatbots and other mental health devices that use generative AI. By Mario Aguilar Opinion: The dangerous illusion of 'peer-to-peer' review for prior authorization Insurance company-mandated peer-to-peer prior authorization reviews are opaque and unaccountable, physician writes. By Alexa B. Kimball

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser